719 related articles for article (PubMed ID: 28648567)
1. Eicosapentaenoic and docosahexaenoic acids have different effects on peripheral phospholipase A2 gene expressions in acute depressed patients.
Su KP; Yang HT; Chang JP; Shih YH; Guu TW; Kumaran SS; Gałecki P; Walczewska A; Pariante CM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):227-233. PubMed ID: 28648567
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.
Chang JP; Chang SS; Chen HT; Chien YC; Yang HT; Huang SY; Tseng PT; Chang CH; Galecki P; Su KP
Brain Behav Immun; 2023 Aug; 112():125-131. PubMed ID: 37301235
[TBL] [Abstract][Full Text] [Related]
3. International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder.
Guu TW; Mischoulon D; Sarris J; Hibbeln J; McNamara RK; Hamazaki K; Freeman MP; Maes M; Matsuoka YJ; Belmaker RH; Jacka F; Pariante C; Berk M; Marx W; Su KP
Psychother Psychosom; 2019; 88(5):263-273. PubMed ID: 31480057
[TBL] [Abstract][Full Text] [Related]
4. Clinical Efficacy and Biological Regulations of ω-3 PUFA-Derived Endocannabinoids in Major Depressive Disorder.
Yang B; Lin L; Bazinet RP; Chien YC; Chang JP; Satyanarayanan SK; Su H; Su KP
Psychother Psychosom; 2019; 88(4):215-224. PubMed ID: 31269506
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder - Results from a randomized controlled trial.
Chang JP; Chang SS; Yang HT; Chen HT; Chien YC; Yang B; Su H; Su KP
Brain Behav Immun; 2020 Mar; 85():14-20. PubMed ID: 30902738
[TBL] [Abstract][Full Text] [Related]
6. Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment.
Saunders EF; Reider A; Singh G; Gelenberg AJ; Rapoport SI
Bipolar Disord; 2015 Nov; 17(7):729-42. PubMed ID: 26424416
[TBL] [Abstract][Full Text] [Related]
7. Low omega-3 polyunsaturated fatty acids predict reduced response to standard antidepressants in patients with major depressive disorder.
Cussotto S; Delgado I; Oriolo G; Kemper J; Begarie D; Dexpert S; Sauvant J; Leboyer M; Aouizerate B; Martin-Santos R; Schaefer M; Capuron L
Depress Anxiety; 2022 May; 39(5):407-418. PubMed ID: 35357051
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression.
Sublette ME; Ellis SP; Geant AL; Mann JJ
J Clin Psychiatry; 2011 Dec; 72(12):1577-84. PubMed ID: 21939614
[TBL] [Abstract][Full Text] [Related]
9. Effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular disease risk factors: a randomized clinical trial.
Asztalos IB; Gleason JA; Sever S; Gedik R; Asztalos BF; Horvath KV; Dansinger ML; Lamon-Fava S; Schaefer EJ
Metabolism; 2016 Nov; 65(11):1636-1645. PubMed ID: 27733252
[TBL] [Abstract][Full Text] [Related]
10. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
Martins JG
J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder.
Mocking RJ; Harmsen I; Assies J; Koeter MW; Ruhé HG; Schene AH
Transl Psychiatry; 2016 Mar; 6(3):e756. PubMed ID: 26978738
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial.
Su KP; Lai HC; Yang HT; Su WP; Peng CY; Chang JP; Chang HC; Pariante CM
Biol Psychiatry; 2014 Oct; 76(7):559-66. PubMed ID: 24602409
[TBL] [Abstract][Full Text] [Related]
13. The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer's disease: Acting separately or synergistically?
Song C; Shieh CH; Wu YS; Kalueff A; Gaikwad S; Su KP
Prog Lipid Res; 2016 Apr; 62():41-54. PubMed ID: 26763196
[TBL] [Abstract][Full Text] [Related]
14. Omega-3 polyunsaturated fatty acids protect against inflammation through production of LOX and CYP450 lipid mediators: relevance for major depression and for human hippocampal neurogenesis.
Borsini A; Nicolaou A; Camacho-Muñoz D; Kendall AC; Di Benedetto MG; Giacobbe J; Su KP; Pariante CM
Mol Psychiatry; 2021 Nov; 26(11):6773-6788. PubMed ID: 34131267
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid reduces resting blood pressure but increases muscle sympathetic outflow compared with eicosapentaenoic acid in healthy men and women.
Lee JB; Notay K; Klingel SL; Chabowski A; Mutch DM; Millar PJ
Am J Physiol Heart Circ Physiol; 2019 Apr; 316(4):H873-H881. PubMed ID: 30735073
[TBL] [Abstract][Full Text] [Related]
16. Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature.
Kalkman HO; Hersberger M; Walitza S; Berger GE
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922396
[TBL] [Abstract][Full Text] [Related]
17. n-3 Fatty acids regulate the inflammatory-state related genes in the lung epithelial cells exposed to polycyclic aromatic hydrocarbons.
Gdula-Argasińska J; Czepiel J; Totoń-Żurańska J; Wołkow P; Librowski T; Czapkiewicz A; Perucki W; Woźniakiewicz M; Woźniakiewicz A
Pharmacol Rep; 2016 Apr; 68(2):319-28. PubMed ID: 26922534
[TBL] [Abstract][Full Text] [Related]
18. Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.
Carney RM; Steinmeyer BC; Freedland KE; Rubin EH; Rich MW; Harris WS
J Clin Psychiatry; 2016 Feb; 77(2):e138-43. PubMed ID: 26930527
[TBL] [Abstract][Full Text] [Related]
19. Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans.
Ostermann AI; West AL; Schoenfeld K; Browning LM; Walker CG; Jebb SA; Calder PC; Schebb NH
Am J Clin Nutr; 2019 May; 109(5):1251-1263. PubMed ID: 31006007
[TBL] [Abstract][Full Text] [Related]
20. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
JAMA; 2009 Oct; 302(15):1651-7. PubMed ID: 19843899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
